Eric S. Surrey — Endo Lab

article 1998

LEUPROLIDE ACETATE DEPOT AND HORMONAL ADD-BACK IN ENDOMETRIOSIS

·doi:10.1097/00006250-199805000-00030

Hornstein, Mark D. MD; Surrey, Eric S. MD; Weisberg, Gerald W. MD; Casino, Leigh A. MT Author Information

article 1997

An economically rational method of managing early-stage endometriosis.

Medical interface

Endometriosis is a common gynecologic disease among women of reproductive age. The lesions of early endometriosis may be missed during laparoscopy, which has been considered to be the definitive means of both diagnosis and treatment. Moreov…

article 1995

Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy

·doi:10.1016/s0015-0282(16)57476-7

ObjectiveTo examine the safety and efficacy of combining cyclic sodium etidronate and low-dose norethindrone with a long-acting GnRH agonist (GnRH-a) for prolonged therapy of symptomatic endometriosis.DesignProspective randomized open label…

article 1993

The effect of growth factors on the proliferation of human endometrial stromal cells in culture

American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(93)90356-n

ObjectiveDevelopment of ectopic implants of endometriosis is associated with both an inflammatory response by macrophages and endometrial stromal cell proliferation. Macrophages are capable of releasing a variety of inflammatory mediators, …

article 1992

Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro

Fertility and Sterility ·doi:10.1016/s0015-0282(16)55199-1

ObjectiveTo assess the direct effects of three endometriosis chemotherapeutic agents (medroxyprogesterone acetate [MPA], danazol, and leuprolide acetate [LA]) on endometrial cell proliferation.DesignAnalysis of cell proliferation in vitro.S…

article 1992

Falloposcopic classification and treatment of fallopian tube lumen disease

·doi:10.1016/s0015-0282(16)54951-6

ObjectiveTo devise a diagnostic classification and scoring system for tubal lumen disease based on falloposcopy and to evaluate it against tuboplasty procedures and pregnancy outcomes.DesignProspective study approved by the hospital Institu…

article 1992

Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.

The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.75.2.1386374

The hypoestrogenic state induced by gonadotropin-releasing hormone agonists (GnRHa) has been shown to suppress symptomatic endometriosis effectively but to elicit vasomotor symptoms and loss of bone mineral density. The role of norethindron…

article 1991

Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: a model for endometriosis?

Fertility and Sterility ·doi:10.1016/s0015-0282(16)54598-1

ObjectiveTo assess the direct effects of platelet-derived growth factor (PDGF), a macrophage secretory product structurally and functionally similar to substances released by peritoneal macrophages isolated from endometriosis patients, on e…

article 1990

Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro

Obstetrics and gynecology ·doi:10.1097/00006250-199011000-00013

Late proliferative phase endometrial stromal cells grown in short-term culture were used as a model for the stromal component of endometriotic implants. Cells were grown in medium alone and in medium supplemented by 5, 10, and 20% concentra…

article 1990

Endometriosis and infertility: the mechanisms involved.

Progress in clinical and biological research

article 1990

The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis

·doi:10.1016/s0015-0282(16)53453-0

Treatment of endometriosis with gonadotropin-releasing hormone agonists (GnRH-a) is associated with side effects secondary to the induced hypoestrogenic state. In an effort to ameliorate these symptoms, 10 patients with symptomatic endometr…

article 1990

The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis

Fertility and Sterility ·doi:10.1016/0020-7292(90)90540-2

Treatment of endometriosis with gonadotropin-releasing hormone agonists (GnRH-a) is associated with side effects secondary to the induced hypoestrogenic state. In an effort to ameliorate these symptoms, 10 patients with symptomatic endometr…

article 1990

The Effects of Combining Norethindrone with a Gonadotropin-Releasing Hormone Agonist in the Treatment of Symptomatic Endometriosis

·doi:10.1097/00006254-199009000-00020

SURREY, ERIC S.; GAMBONE, JOSEPH C.; LU, JOHN K. H.; JUDD, HOWARD L. Author Information

article 1989

Endometriosis as a Cause of Infertility

Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(21)00139-x

Although association between moderate or severe endometriosis and infertility is fairly well established, the link between lesser disease stages and infertility is more tenuous. The proposed mechanisms underlying this association are review…